279 related articles for article (PubMed ID: 16679865)
1. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
2. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
3. An incident case-referent study on plasma enterolactone and breast cancer risk.
Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
[TBL] [Abstract][Full Text] [Related]
4. Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
[TBL] [Abstract][Full Text] [Related]
5. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
6. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.
Iwasaki M; Inoue M; Otani T; Sasazuki S; Kurahashi N; Miura T; Yamamoto S; Tsugane S;
J Clin Oncol; 2008 Apr; 26(10):1677-83. PubMed ID: 18316793
[TBL] [Abstract][Full Text] [Related]
7. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
8. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.
Piller R; Verla-Tebit E; Wang-Gohrke S; Linseisen J; Chang-Claude J
J Nutr; 2006 Jun; 136(6):1596-603. PubMed ID: 16702327
[TBL] [Abstract][Full Text] [Related]
9. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
Zeleniuch-Jacquotte A; Adlercreutz H; Akhmedkhanov A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):885-9. PubMed ID: 9796633
[TBL] [Abstract][Full Text] [Related]
10. Enterolactone as a risk factor for breast cancer: a review of the published evidence.
Boccardo F; Puntoni M; Guglielmini P; Rubagotti A
Clin Chim Acta; 2006 Mar; 365(1-2):58-67. PubMed ID: 16168401
[TBL] [Abstract][Full Text] [Related]
11. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
Dai Q; Franke AA; Jin F; Shu XO; Hebert JR; Custer LJ; Cheng J; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum enterolactone, genistein, and daidzein in a dietary intervention study in Finland.
Stumpf K; Pietinen P; Puska P; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1369-72. PubMed ID: 11142423
[TBL] [Abstract][Full Text] [Related]
14. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
[TBL] [Abstract][Full Text] [Related]
15. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
16. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
17. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study.
Linseisen J; Piller R; Hermann S; Chang-Claude J;
Int J Cancer; 2004 Jun; 110(2):284-90. PubMed ID: 15069695
[TBL] [Abstract][Full Text] [Related]
18. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
[TBL] [Abstract][Full Text] [Related]
19. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada).
Thanos J; Cotterchio M; Boucher BA; Kreiger N; Thompson LU
Cancer Causes Control; 2006 Dec; 17(10):1253-61. PubMed ID: 17111256
[TBL] [Abstract][Full Text] [Related]
20. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
McCann SE; Kulkarni S; Trevisan M; Vito D; Nie J; Edge SB; Muti P; Freudenheim JL
Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
